American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
AbbVie
ABBV
|
+$279M |
| 2 |
L3Harris
LHX
|
+$252M |
| 3 |
NVIDIA
NVDA
|
+$249M |
| 4 |
VeriSign
VRSN
|
+$217M |
| 5 |
Jacobs Solutions
J
|
+$212M |
Top Sells
| 1 |
Texas Instruments
TXN
|
+$460M |
| 2 |
Meta Platforms (Facebook)
META
|
+$426M |
| 3 |
Adobe
ADBE
|
+$374M |
| 4 |
PayPal
PYPL
|
+$304M |
| 5 |
iShares Russell Mid-Cap Value ETF
IWS
|
+$278M |
Sector Composition
| 1 | Technology | 20.49% |
| 2 | Financials | 14.96% |
| 3 | Healthcare | 14.78% |
| 4 | Consumer Discretionary | 11.09% |
| 5 | Industrials | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Intel
INTC
$107B
| $123M | 0.1% |
3,284,146
+778,603
| +31% | +$29.1M |
|
227
TransDigm Group
TDG
$72.9B
| $123M | 0.1% |
228,353
+220,632
| +2,858% | +$118M |
|
228
Korn Ferry
KFY
$3.79B
| $122M | 0.1% |
2,110,254
+234,287
| +12% | +$13.6M |
|
229
J.M. Smucker
SJM
$11.9B
| $122M | 0.1% |
952,765
+230,721
| +32% | +$29.5M |
|
230
Yeti Holdings
YETI
$2.9B
| $121M | 0.1% |
2,807,551
+14,145
| +0.5% | +$612K |
|
231
Abbott
ABT
$230B
| $121M | 0.1% |
1,113,654
-261,031
| -19% | -$28.4M |
|
232
Compass Diversified
CODI
$544M
| $120M | 0.1% |
5,609,213
-316,070
| -5% | -$6.77M |
|
233
Gilead Sciences
GILD
$144B
| $119M | 0.1% |
1,928,878
+1,301,884
| +208% | +$80.5M |
|
234
Atlassian
TEAM
$45.3B
| $119M | 0.1% |
636,032
-191,277
| -23% | -$35.8M |
|
235
Steris
STE
$24.5B
| $119M | 0.1% |
577,980
-575,611
| -50% | -$119M |
|
236
Clarivate
CLVT
$3.01B
| $117M | 0.1% |
8,429,754
-18,527
| -0.2% | -$257K |
|
237
GFL Environmental
GFL
$17.2B
| $116M | 0.1% |
4,512,451
+968,871
| +27% | +$25M |
|
238
TJX Companies
TJX
$157B
| $116M | 0.09% |
2,074,470
+1,421,540
| +218% | +$79.4M |
|
239
Old National Bancorp
ONB
$8.96B
| $115M | 0.09% |
7,784,750
+306,144
| +4% | +$4.53M |
|
240
Heartland Express
HTLD
$668M
| $115M | 0.09% |
8,259,868
+132,152
| +2% | +$1.84M |
|
241
Bio-Techne
TECH
$8.42B
| $113M | 0.09% |
1,306,636
-43,588
| -3% | -$3.78M |
|
|
CHX
242
DELISTED
ChampionX
CHX
| $113M | 0.09% |
5,703,666
-23,154
| -0.4% | -$460K |
|
243
Hanover Insurance
THG
$6.36B
| $113M | 0.09% |
773,611
+689,849
| +824% | +$101M |
|
244
Avnet
AVT
$4.45B
| $112M | 0.09% |
2,622,521
-579,566
| -18% | -$24.9M |
|
245
VICI Properties
VICI
$35.5B
| $112M | 0.09% |
3,767,234
+2,401,411
| +176% | +$71.5M |
|
246
Edgewell Personal Care
EPC
$1.05B
| $110M | 0.09% |
3,193,535
+64,976
| +2% | +$2.24M |
|
247
Essex Property Trust
ESS
$17.1B
| $110M | 0.09% |
419,409
-71,694
| -15% | -$18.7M |
|
248
Rockwell Automation
ROK
$38.8B
| $109M | 0.09% |
547,679
-579,626
| -51% | -$116M |
|
249
Neurocrine Biosciences
NBIX
$14.3B
| $108M | 0.09% |
1,112,832
+316,984
| +40% | +$30.9M |
|
250
Verisk Analytics
VRSK
$38.1B
| $106M | 0.09% |
615,006
+20,802
| +4% | +$3.6M |
|